Testing effectiveness (Phase 2)Looking for participantsNCT06209736
What this trial is testing
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Who this might be right for
C3 GlomerulopathyIdiopathic Immune Complex-Mediated Glomerulonephritis
Omeros Corporation 20